Man Group
BNGO icon

Man Group’s Bionano Genomics BNGO Stock Holding History

Man Group’s Portfolio BNGO Stock Details BNGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Hold
0
– – – 1774
2022
Q4 		– Sell
-41
Closed -$45K – 2011
2022
Q3 		$45K Buy
+41
New +$54.2K ﹤0.01% 1905
2021
Q3 		– Sell
-194
Closed -$852K – 1908
2021
Q2 		$852K Buy
+194
New +$766K ﹤0.01% 1423

Other funds holding BNGO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $149B AUM 24.71% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Man Group's BNGO Position: Q3 2023 in Review

Man Group held its Bionano Genomics (BNGO) position steady in Q3 2023 at 0 shares worth $182K. The position accounts for ﹤0.01% of the portfolio, ranked #1774.

Man Group first reported a position in BNGO in Q2 2021 and has held it in 2 quarters since. The position peaked at $852K in Q2 2021. 46 funds tracked by Wall St. Rank hold BNGO as of Q3 2023.

  • Man Group held 0 shares of Bionano Genomics worth $182K as of Q3 2023.
  • Man Group left its Bionano Genomics share count unchanged in Q3 2023.
  • Bionano Genomics made up ﹤0.01% of Man Group's portfolio in Q3 2023, its #1774 holding.
  • Man Group first reported a position in Bionano Genomics in Q2 2021 and has held it in 2 quarters since.
  • Man Group's Bionano Genomics position peaked at $852K in Q2 2021.
  • 46 funds tracked by Wall St. Rank held Bionano Genomics as of Q3 2023.

Based on Man Group's 13F filing for Q3 2023, filed 14 Nov 2023.